Assurance of reliable blood pressure measurement is one of several important considerations for those responsible for the design and conduct of programs for blood pressure screening and control. One important source of error in blood pressure measurement is the observer. Systematic differences in blood pressure determinations among observers can be caused by such factors as differences in auditory acuity, in the rate of decreasing the cuff pressure, and in terminal digit preference, the tendency of an individual observer to record certain numbers in preference to others. Under field conditions, fatigue, team morale and ot-her factors may also reduce the reliability of blood pressure measurements. Although training can produce adequate standardization of blood pressure measurement by the standard cuff-and-auscultatory technique, it would be very desirable for mass screening programs to have a blood pressure measurement device intrinsically free of observer errors such as those mentioned above.
Several devices have recently been made available that measure blood pressure by methods less dependent upon the human observer, and this Committee has been asked to provide recommendations concerning their use in mass screening programs. However these devices is still too limited to warrant specific recommendations. The Committee urges that a program of systematic evaluation be undertaken to provide data as a basis for specific recommendations in the future.
The Committee does suggest a list of characteristics desirable for blood pressure measurement devices used in mass screening programs. In constructing this list, the Committee has been guided by the belief that the current method-that is, the standard cuff and auscultatory technique-has been used for so long and has provided so much of our current data on blood pressure that any new measurement technique or device must be evaluated against this procedure and these results as the standard. It should be noted that no device currently available is known to meet all of these specifications, and the extent to which certain specifications are met by specific devices remains to be determined through adequate evaluation. Accordingly, the list presented above is applicable only as a guide, for potential users of any method of blood pressure measurement, to indicate characteristics which merit consideration. Other specific applications such as blood pressure measurement during exercise or continuous blood pressure monitoring, would require a modified set of criteria. The relative priorities among these points in selection of a method may be dictated by specific screening applications. It is hoped that awareness of the limitations specific to any method will aid in the interpretation of measurements and the assessments of the results of screening programs.
At this time a program of evaluation of measurement devices appears warranted. Such a program should in the long run involve the manufacturers, independent research organizations qualified to perform sound experimental tests, and screening programs themselves as a basis for actual field experience with those devices found at the prior stages to merit this level of evaluation. The Appendix to this document is an outline of one approach to an evaluation program of this kind.
The Committee, while addressing the specific issue of measurement in screening programs, wishes to emphasize that this is not the sole issue with which program planners must be concerned. An adequate community program to control high blood pressure consists of at least four phases: detection, diagnosis, effective treatment, and long-term management. Evidence from many different populations has shown that the majority of persons with high blood pressure were not aware of their condition. Screening programs are a necessary first step in the community control of high blood pressure, in order to identify such persons, and experience has shown that such programs can be highly effective. However, mass screening can accomplish little or nothing in the way of control of high blood pressure unless it is an element of an adequate program of diagnosis, effective treatment, and long-term management, including reduction in medication level, when possible without loss of blood pressure control. In fact mass screening alone can be counter-productive, if ample facilities are not provided for treating high blood pressure-that is, if it generates concern about blood pressure without insuring effective referral and follow-up or if the medical community is not fully prepared to provide patient supervision by having accepted the general criteria for therapy of hypertension. This Committee strongly urges, therefore, that large scale screening programs intended to reduce morbidity and mortality from high blood pressure be undertaken only as part of an integrated, carefully planned control program that includes adequate backup facilities for diagnosis, effective treatment and long-term management, however these elements may be organized within a particular community.
Appendix A Program for Evaluation of Blood Pressure Measurement Devices
A program for evaluation of blood pressure measurement devices should include several aspects: The design specifications of the manufacturer; experimental evaluation under laboratory, clinical and field conditions; and monitoring of performance in the course of actual screening activities in the field. Information should be collected sequentially in each of these respects to permit the most appropriate assessment of the suitability of a given device for use in blood pressure screening and control. The purpose of observation in each of these respects is as follows:
Manufacturer's specifications:
Certain features descriptive of a particular device and its operation may in themselves suggest its relative suitability for a given program. In general, statements provided by the manufacturer in sales literature, or in reports of experience by others, should be confirmed by direct observation, as through procedures outlined in the subsequent sections of this appendix.
Laboratory tests:
Once a unit of a particular device is available for evaluation, several characteristics can be tested by inspection or by operation, even ily carried out both for operation and simple maintenance of the device. 3. Application!Sensitivity: Application of the device to the subject-that is, placement of the cuff-should be easily and quickly accomplished, and the determination of systolic and diastolic pressure should be insensitive to small variations in position or technique of application. The amount of undressing and special requirements for positioning of subject should be stated. 4. Arm girth: The minimum and maximum arm girths for which the device is designed and any other limits on dimension of subjects should be specified by the manufacturer. 5. Automaticity: The degree of automaticity of the device should be described together with provision for manual overrides for such components of the system as inflation and deflation, determination of systole and diastole, recording of the pressures and recycling. 6. Flow control: The way in which the deflation rate is controlled and characteristics of the deflation cycle should be described. 7. Output form: The mode for displaying blood pressure readings should be described. Preferably a permanent record should be generated which minimizes the operator's role in reading and recording the pressures. It would be desirable for the output record to indicate the quality of the measurement, i.e. occurrence of artifacts, presence of arrhythmias, or improper functioning of the device.
Confidentiality: Confidentiality of findings
should be assured by a design which makes the output immediately accessible only to the operator (that is, neither the subject nor bystanders should be able to see the readings as the record is being generated). 9. Safety: The device should be free from electrical, mechanical, or other hazards to the subject and to the operator. In the event of equipment malfunction, cuff pressure should deflate to atmospheric. Provision for avoidance of over inflation or prolonged inflation should be described. 10. Portability: The portability of the device with respect to weight, size, power supply, ruggedness and time required for setting up and taking down the screening station should be described.
Ease of calibration:
The device should be designed so that its calibration can be checked and adjusted by the operator in the field. 12. Calibration method: The procedure for calibrating the pressure system should be based on direct comparison between the output of the device and known pressures determined independently by a mercury manometer or other standard reference over at least the range of pressures from 50 to 200 mm Hg. 13. Ease of repair: Common repairs and adjustments, such as replacement of a stylus, should be readily manageable by the operator in the field. The device should be constructed so that more extensive repairs can be performed by qualified local service persons or manufacturers' agents without undue delay. Appropriate service manuals should be provided. 14. Cost: The costs for the basic equipment, accessories, supplies and set-ups and maintenance should be specified and must be within practical limitations of community resources for blood pressure control programs. 15. Training: The time and resources required for training in use of the device should be described. 16. Measurement accuracy: The determination of systolic and diastolic pressures by the device should agree with measurements made by adequately trained observers using the standard mercury sphygmomanometer at least over the intended range of arm girths and at least over the range of pressures from 50 to 120 mm Hg, for diastolic blood pressure, and from 80 to 200 mm Hg, for systolic blood pressure. If disagreement does exist, its magnitude and direction must be known at least over these specified ranges of pres- without a subject available for actual blood pressure measurement. For example, safety features, performance of flow rate controls, and accessibility of calibration points can be assessed. The extent of such evaluation is limited at present because no suitable system is commonly available to generate artificial blood pressure signals for laboratory measurement. 3 
. Clinical tests:
With a subject and device together, actual measurements can be obtained and a number of additional features tested, including measurement bias and comparability of multiple units of the same device. (These procedures require careful experimental design, which may depend heavily on specific features of the device or devices being tested at a particular time.)
Field tests:
Many features of measurement performance require evaluation under simulated or actual field conditions. These features include, for example, performance in the presence of common levels of background noise and the effect of movement of the device on calibration or on preset mechanical components such as flow rate control. In addition, effects of prolonged work periods on observer performance require testing under these conditions, including comparison with the standard device.
Monitoring in field use:
The evaluation of devices acceptable through the preceding 4 phases should be extended to long-term monitoring of their performance under actual field circumstances, through X X X X X X X X X X X X X X X X X X X X X X the course of a screening program. The resulting information cannot practically be as firmly based as the experimental results previously obtained; however, experience from long-term use should not be ignored and may affect importantly the selection of measurement methods for future screening in the same or other populations. Durability, long-term safety, and suggestions of trends in measurement performance are examples of characteristics in this general class. These five approaches to evaluation are arrayed against the characteristics listed previously, to indicate in a single table the elements which a comprehensive evaluation might include (see table 1 ).
Specific questions which apply to the cells checked in this table include the following (numbers correspond to columns in the table):
